Literature DB >> 4041344

The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow.

P A Meredith, F Pasanisi, H L Elliott, J L Reid.   

Abstract

The effects of the acute and continued administration of the calcium antagonist nisoldipine on hepatic and renal blood flow and on renal function were studied in nine normotensive volunteers. There were no significant changes in supine blood pressure or heart rate but acute administration significantly increased both apparent liver blood flow and effective renal plasma flow. With continued administration these increases were attenuated and were not significantly different from placebo after 4 days treatment. Acute nisoldipine administration was also associated with significant increases in glomerular filtration rate and urinary sodium excretion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041344      PMCID: PMC1400696          DOI: 10.1111/j.1365-2125.1985.tb05066.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

Review 1.  Drug kinetics and hepatic blood flow.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

2.  Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.

Authors:  C K Svensson; D J Edwards; P M Mauriello; S H Barde; A C Foster; R A Lanc; E Middleton; D Lalka
Journal:  Clin Pharmacol Ther       Date:  1983-09       Impact factor: 6.875

3.  Verapamil pharmacokinetics and apparent hepatic and renal blood flow.

Authors:  P A Meredith; H L Elliott; F Pasanisi; A W Kelman; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

4.  Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.

Authors:  J Feely
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

5.  [Effects of intravenous nicardipine hydrochloride (YC 93), a calcium antagonist, on renal function (author's transl)].

Authors:  S Yokoyama; T Kaburagi
Journal:  Nihon Jinzo Gakkai Shi       Date:  1981-08

6.  Clinical effects of intravenous nifedipine on renal function.

Authors:  S Yokoyama; T Kaburagi
Journal:  J Cardiovasc Pharmacol       Date:  1983 Jan-Feb       Impact factor: 3.105

  6 in total
  16 in total

Review 1.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

2.  Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men.

Authors:  B Bengtsson-Hasselgren; O Rönn; L O Blychert; B Edgar; S Raner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.

Authors:  H L Elliott; P A Meredith; C McNally; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

4.  The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.

Authors:  J van Harten; J Burggraaf; M Danhof; P van Brummelen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

5.  Verapamil pharmacokinetics.

Authors:  P A Meredith; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

Review 6.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

7.  Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure.

Authors:  P H Dunselman; B Edgar; A H Scaf; C E Kuntze; H Wesseling
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

Review 8.  Drug interactions with thrombolytic agents. Current perspectives.

Authors:  A de Boer; J M van Griensven
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

9.  Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.

Authors:  W Kirch; J Stenzel; P Dylewicz; H J Hutt; S R Santos; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of nicotine.

Authors:  C K Svensson
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.